ZARBO, Ignazio Roberto
 Distribuzione geografica
Continente #
NA - Nord America 2.229
AS - Asia 1.538
SA - Sud America 1.162
EU - Europa 768
AF - Africa 79
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 5.783
Nazione #
US - Stati Uniti d'America 2.159
BR - Brasile 1.033
SG - Singapore 640
CN - Cina 371
VN - Vietnam 153
IT - Italia 147
UA - Ucraina 139
DE - Germania 131
HK - Hong Kong 122
FR - Francia 70
GB - Regno Unito 56
SE - Svezia 46
AR - Argentina 39
FI - Finlandia 37
IQ - Iraq 37
BD - Bangladesh 35
MX - Messico 32
ZA - Sudafrica 32
RU - Federazione Russa 28
IN - India 25
TR - Turchia 25
CA - Canada 24
EC - Ecuador 23
PK - Pakistan 23
VE - Venezuela 22
CZ - Repubblica Ceca 21
NL - Olanda 16
PL - Polonia 16
TN - Tunisia 16
ES - Italia 15
UZ - Uzbekistan 15
CO - Colombia 13
JP - Giappone 12
PY - Paraguay 12
PE - Perù 10
AE - Emirati Arabi Uniti 9
AT - Austria 9
ID - Indonesia 9
LT - Lituania 9
MA - Marocco 9
BE - Belgio 8
JO - Giordania 7
SA - Arabia Saudita 7
DO - Repubblica Dominicana 6
AZ - Azerbaigian 5
CL - Cile 5
KR - Corea 5
BW - Botswana 4
KE - Kenya 4
KZ - Kazakistan 4
PH - Filippine 4
AO - Angola 3
BG - Bulgaria 3
DZ - Algeria 3
EU - Europa 3
HN - Honduras 3
KG - Kirghizistan 3
OM - Oman 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CR - Costa Rica 2
EG - Egitto 2
IE - Irlanda 2
IL - Israele 2
KW - Kuwait 2
MY - Malesia 2
NP - Nepal 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AM - Armenia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
IR - Iran 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
MV - Maldive 1
QA - Qatar 1
RE - Reunion 1
SR - Suriname 1
SV - El Salvador 1
TW - Taiwan 1
UY - Uruguay 1
Totale 5.782
Città #
Dallas 685
Singapore 342
San Jose 232
Chandler 201
Ashburn 138
Hong Kong 119
Beijing 95
Jacksonville 80
São Paulo 77
Princeton 58
Munich 50
Lauterbourg 49
New York 48
Ho Chi Minh City 46
Shanghai 45
Los Angeles 41
Rio de Janeiro 36
Hanoi 31
Belo Horizonte 29
Nanjing 28
Dearborn 25
Santa Clara 25
Sassari 24
Helsinki 21
Ann Arbor 20
Baghdad 20
Wilmington 20
Brasília 18
Brno 17
Johannesburg 17
London 17
Porto Alegre 17
Campinas 16
Nanchang 15
Orem 15
Brooklyn 13
Curitiba 13
Fortaleza 13
Salvador 13
Warsaw 13
Guarulhos 12
Tashkent 12
Boardman 11
Tokyo 11
Cagliari 10
Da Nang 10
Denver 10
Frankfurt am Main 10
Hebei 10
Mountain View 10
Amsterdam 9
Chennai 9
Haiphong 9
Joinville 9
Lima 9
Nuremberg 9
Rome 9
Tunis 9
Boston 8
Brussels 8
Changsha 8
Columbus 8
Council Bluffs 8
Istanbul 8
Jiaxing 8
Ribeirão Preto 8
Ribeirão das Neves 8
San Francisco 8
Santo André 8
Shenyang 8
Amman 7
Buffalo 7
Canoas 7
Düsseldorf 7
Guayaquil 7
Poplar 7
Stockholm 7
São Gonçalo 7
Tianjin 7
Volta Redonda 7
Washington 7
Asunción 6
Caruaru 6
Houston 6
Manchester 6
Mexico City 6
Quito 6
The Dalles 6
Toronto 6
Vienna 6
Atlanta 5
Baku 5
Bauru 5
Campo Grande 5
Cape Town 5
Caracas 5
Carapicuíba 5
Criciúma 5
Cuiabá 5
Dhaka 5
Totale 3.237
Nome #
A rare case of lupus-like syndrome during treatment with interferon β-1a. 221
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 192
Herv-k modulates the immune response in als patients 181
Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis 154
Personality traits predict perceived health-related quality of life in persons with multiple sclerosis 152
Corpus callosum volumetrics and clinical progression in early multiple sclerosis 146
Antihuman Endogenous Retrovirus Immune Response and Adaptive Dysfunction in Autism 143
Cladribine vs other drugs in MS: Merging randomized trial with real-life data 139
Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study 138
Treadmill-virtual reality combined training program to improve gait in multiple sclerosis individuals 135
Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis Patients 134
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study 134
An innovative training program based on virtual reality and treadmill: effects on gait of persons with multiple sclerosis 134
Proteomic analysis of CSF in multiple sclerosis patients and controls: a study in Sardinian population 130
First evidence of the cross-training effect in multiple sclerosis 128
Long-term trajectory of acquired demyelinating syndrome and multiple sclerosis in children 127
Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis 127
ADEM o sclerosi Multipla: la comunicazione di una diagnosi difficile 122
Signs and symptoms of COVID-19 in patients with multiple sclerosis 119
A multi-element psychosocial intervention for early psychosis (GET UP PIANO TRIAL) conducted in a catchment area of 10 million inhabitants: study protocol for a pragmatic cluster randomized controlled trial 118
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 118
Cross-sectional analysis of the humoral response after SARS-CoV-2 vaccination in Sardinian multiple sclerosis patients, a follow-up study 116
Inflammation, infectious triggers, and Parkinson's disease 115
MSRV as a prognostic factor in Sardinian patients: 10-year follow-up 113
A six-week intensive treadmill training improves walking ability in MS patients with moderate disability 112
Intensive treadmill training improves gait in moderately impaired multiple sclerosis individuals 111
Virtual reality-treadmill training to improve gait in people with multiple sclerosis 109
Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination 107
Natalizumab as treatment option of refractory epilepsy in multiple sclerosis. 104
The Effect of Contralateral Strength Training on Muscle Weakness in People With Multiple Sclerosis: A Proof-of-Concept Case Series. 102
Tdp‐43 and herv‐k envelope‐specific immunogenic epitopes are recognized in als patients 102
Influence of psychological and social factors on self perceived health-related quality of life in patients with multiple sclerosis 99
Prolonged B-cell depletion after rituximab in AQP4-IgG-positive neuromyelitis optica spectrum disorder 96
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 95
Sclerosi combinata del midollo, neuropatia ottica e deterioramento cognitivo post-resezione intestinale. Ruolo patogenetico della carenza di oligoelementi? 93
Paresi del IX e X nervi cranici da ematoma parietale post-traumatico della carotide interna in paziente con crisi convulsiva 92
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 88
Maternal multiple sclerosis is not a risk factor for neurodevelopmental disorders in offspring 86
HERV-W/MSRV in the CSF significantly predicts the secondary progressive MS course upon 10-years follow-up 85
Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies 84
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 84
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study 84
Network analysis of gut microbial communities reveal key genera for a multiple sclerosis cohort with Mycobacterium avium subspecies paratuberculosis infection 81
RNA-binding proteins in autoimmunity: From genetics to molecular biology 81
The role of ethnicity and native-country income in multiple sclerosis: the Italian multicentre study (MS-MigIT) 75
Multiple Sclerosis Progression and Relapse Activity in Children 74
Determinants of self-perceived quality of life in mildly disabled multiple sclerosis patients: a cross-sectional study 73
Mycobacterium avium subspecies paratuberculosis (MAP) infection, and its impact on gut microbiome of individuals with multiple sclerosis 73
On a 5-year-old girl with multiple sclerosis treated with natalizumab 70
The Impact of Autistic Traits on Quality of Life and Symptom Severity in Multiple Sclerosis Patients: A Cross-Sectional Study 67
Identification of hsa_circ_0018905 as a New Potential Biomarker for Multiple Sclerosis 66
Rasagiline Withdrawal Syndrome in Parkinson’s Disease 62
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study 54
Totale 5.845
Categoria #
all - tutte 23.880
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.880


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 0 0 8
2021/2022156 13 0 3 1 2 2 3 23 13 27 12 57
2022/2023366 29 48 6 61 43 47 1 34 56 20 12 9
2023/2024173 16 17 8 6 36 18 1 14 0 7 15 35
2024/20252.034 77 21 136 65 47 69 104 453 620 317 90 35
2025/20262.641 89 597 310 439 286 162 347 71 123 146 58 13
Totale 5.845